| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2000;17:587-591
© 2000 Elsevier Science NL
a Clinic for Cardiovascular Surgery, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland
b Department of Materials and Institute for Biomedical Engineering, ETH-Zurich, Switzerland
Corresponding author. Tel.: +41-1-255-38-01; fax: +41-1-255-43-69
e-mail: gregor.zund{at}chi.usz.ch
Objective: In tissue engineering, three-dimensional biodegradable scaffolds are generally used as a basic structure for cell anchorage, cell proliferation and cell differentiation. The currently used biodegradable scaffolds in cardiovascular tissue engineering are potentially immunogenic, they show toxic degradation and inflammatory reactions. The aim of this study is to establish a new three-dimensional cell culture system within cells achieve uniform distribution and quick tissue development and with no toxic degradation or inflammatory reactions. Methods: Human aortic tissue is harvested from the ascending aorta in the operation room and worked up to pure human myofibroblasts cultures. These human myofibroblasts cultures are suspended in fibrinogen solution and seeded into 6-well culture plates for cell development for 4 weeks and supplemented with different concentrations of aprotinin. Hydroxyproline assay and histological studies were performed to evaluate the tissue development in these fibrin gel structures. Results: The light microscopy and the transmission electron microscopy studies for tissue development based on the three-dimensional fibrin gel structures showed homogenous cell growth and confluent collagen production. No toxic degradation or inflammatory reactions could be detected. Furthermore, fibrin gel myofibroblasts structures dissolved within 2 days in medium without aprotinin, but medium supplemented with higher concentration of aprotinin retained the three-dimensional structure and had a higher collagen content (P<0.005) and a better tissue development. Conclusions: A three-dimensional fibrin gel structure can serve as a useful scaffold for tissue engineering with controlled degradation, excellent seeding effects and good tissue development.
Key Words: Tissue engineering • Scaffold • Fibrin gel • Cardiovascular
This article has been cited by other articles:
|
|
 |
|
  E. Kniazeva and A. J. Putnam Endothelial cell traction and ECM density influence both capillary morphogenesis and maintenance in 3-D Am J Physiol Cell Physiol, July 1, 2009; 297(1): C179 - C187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M Taylor Biological matrices and bionanotechnology Phil Trans R Soc B, August 29, 2007; 362(1484): 1313 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hasegawa, K. Okada, Y. Takano, Y. Hiraishi, and Y. Okita Autologous fibrin-coated small-caliber vascular prostheses improve antithrombogenicity by reducing immunologic response J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1268 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jux, H. Bertram, P. Wohlsein, M. Brugmann, P. Wuboldt, C. Fink, T. Paul, and G. Hausdorf Experimental ASD closure using autologous cell-seeded interventional closure devices Cardiovasc Res, January 1, 2002; 53(1): 181 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jockenhoevel, G. Zund, S. P. Hoerstrup, K. Chalabi, J. S. Sachweh, L. Demircan, B. J. Messmer, and M. Turina Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering Eur. J. Cardiothorac. Surg., April 1, 2001; 19(4): 424 - 430. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
